The Study
The Impact of frailty on the effectiveness of intensive blood pressure control for patients with type 2 diabetes: a secondary analysis of a randomised controlled trial
This study looked at whether being frail changes how well a blood pressure treatment works in people with diabetes. The treatment was randomly assigned, so we know it causes better heart outcomes. But frailty wasn't randomly assigned — it's just something we noticed about the people, so we can't say frailty causes the difference. We can only say the treatment worked the same whether people were frail or not.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
This study looked at whether older diabetic patients who are frail (weaker, more vulnerable) benefit less from very tight blood pressure control.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 555 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — frailty shouldn't stop doctors from aiming for low BP in diabetics if their sugar is managed normally, but pushing both BP and sugar very low together doesn't help.
- 2In patients with standard diabetes control, lowering BP to <120 mm Hg cut heart attacks/strokes/deaths by 25%.
- 3This benefit was the same whether patients were frail or not.
- 4But if diabetes was tightly controlled, lowering BP further gave no extra benefit.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Heart
Year
2025
Authors
Wenjie Li, Zhiyan Wang, Mingxiao Li, Chao Jiang, Chang Hua, Yangyang Tang, Hao Zhang, Xinru Liu, Shiyue Zheng, Hang Guo, Manlin Zhao, Yu Wang, M. Gao, Qiang Lv, Jianzeng Dong, Changsheng Ma, Xin Du
Related Content
Claims (8)
For frail individuals, aiming for a systolic blood pressure of 120 mm Hg does not improve health outcomes and can lead to adverse effects.
In older adults, how frail a person is matters more than their age when deciding whether lowering blood pressure to below 120 mm Hg is safe and beneficial.
For adults with type 2 diabetes, lowering systolic blood pressure to below 120 mm Hg does not result in fewer major cardiovascular events than lowering it to below 140 mm Hg.
In adults with type 2 diabetes, those who are frail receive more antihypertensive drugs than those who are not frail, no matter whether their blood pressure treatment is standard or intensive.
In adults with type 2 diabetes, lowering blood pressure aggressively reduces cardiovascular events only when blood sugar is managed at a standard level, not when it is managed aggressively.
In adults with type 2 diabetes participating in clinical trials, about 40% show signs of frailty based on the Rockwood index. These individuals are more likely to take antihypertensive medications, but the cardiovascular benefits of lowering blood pressure aggressively are not changed by the presence of frailty.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.